Treatment of Murine Collagen-Induced Arthritis by Ex Vivo Extracellular Superoxide Dismutase Gene Transfer

Arthritis and Rheumatism

Volumn 44, Issue 9, 2001, Pages 2160-2167

  Iyama, Satoshi ^a   Okamoto, Tetsuro ^a   Sato, Tsutomu ^a   Yamauchi, Naofumi ^b   Sato, Yasushi ^a   Sasaki, Katsunori ^a   Takahashi, Minoru ^a   Tanaka, Maki ^a   Adachi, Tetsuo ^c   Kogawa, Katsuhisa ^a   Kato, Junji ^a   Sakamaki, Sumio ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kiyota Hospital   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERLEUKIN 1; MESSENGER RNA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CULTURE MEDIUM; CYTOLOGY; DBA MOUSE; ENZYMOLOGY; EXTRACELLULAR SPACE; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HINDLIMB; HUMAN; JOINT; METABOLISM; MOUSE; PATHOLOGY; PREGNANCY; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA; EXTRACELLULAR SPACE; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; HINDLIMB; HUMANS; INTERLEUKIN-1; JOINTS; MICE; MICE, INBRED DBA; PREGNANCY; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18044399853     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200109)44:9<2160::AID-ART369>3.0.CO;2-0     Document Type: Article

References (46)

1. McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974;185:529-31.
2. Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. J Biol Chem 2000;275:20069-76.
3. Burkhardt H, Schwingel M, Menninger H, Macartney HW, Tschesche H. Oxygen radicals as effectors of cartilage destruction: direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum 1986;29:379-87.
4. Dizdaroglu M, Dirksen ML, Jiang HX, Robbins JH. Ionizing-radiation induced damage in the DNA of cultured human cells. Biochcm J 1987;241:929-32.
5. Simoenova PP, Luster MI. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am J Respir Cell Mol Biol 1995;12:676-83.
6. Koga S, Ogawa S, Kuwabara K, Brett J, Leavy JA, Ryan J, et al. Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J Clin Invest 1992;90:1007-15.
7. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis [review]. Arthritis Rheum 1993;36:1036-44.
8. Biemond P, Swaak AJG, Koster JF. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum 1984;27:760-5.
9. Marklund SL, Bjelle A, Elmqvist L. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis 1986;45:847-51.
10. Shingu M, Takahashi S, Ito M, Hamamatsu N, Suenaga Y, Ichibangase Y, et al. Anti-inflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats. Rheumatol Int 1994;14:77-81.
11. Perizada B, Werber MM, Niemond A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 1991;15:297-301.
12. Kakimoto K, Kojima Y, Ishii K, Onoue K, Maeda H. The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice. Clin Exp Immunol 1993;94:241-6.
13. Karlsson K, Marklund L. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J 1987; 242:55-9.
14. Buters JTM, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, et al. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[α]anthracene-induced lymphomas. Proc Natl Acad Sci U S A 1999;96:1977-82.
15. Wakimoto H, Yoshida Y, Aoyagi M, Hirakawa K, Hamada H. Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn J Cancer Res 1997;88:296-305.
16. Tanaka M, Kogawa K, Nakamura K, Nishibori Y, Kuribayashi K, Hagiwara S, et al. Anti-metastatic gene therapy utilizing subcutaneous inoculation of EC-SOD gene transduced autologous fibroblasts suppressed lung metastasis of Meth A cells in mice. Gene Ther 2001;8:149-56.
17. Marklund SL. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem 1976;251:7504-7.
18. Marklund SL. Handbook of methods for oxygen radical research. Boca Raton (FL): CRC Press; 1985, p. 249-55.
19. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 1982;79:7634-8.
20. Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta 1992;212:89-102.
21. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induced arthritis in mice. Nature 1980;283:666-8.
22. Myers LK. Collagen-induced arthritis. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: Sarah Greene; 1993, p. 15.5.1-24.
23. Callis G, Sterchi D. Decalcification of bone: literature review and practical study of various decalcifying agents, methods, and their effects on bone histology. J Histotech 1998;21:49-58.
24. Zhang H, Yang Y, Horton JL, Samoilova EB, Judge TA, Turka LA, et al. Amelioration of collagen-induced arthritis by CD95 (APO-1/FAS)-ligand gene transfer. J Clin Invest 1997;100:1951-7.
25. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;89:9784-8.
26. Muramatsu H, Kogawa K, Tanaka M, Okumura K, Nishihori Y, Koike K, et al. Superoxide dismutase in SAS human tongue carcinoma cell line is a factor defining invasiveness and cell motility. Cancer Res 1995;55:6210-4.
27. Tanaka M, Kogawa K, Nishihori Y, Kuribayashi K, Nakamura K, Muramatsu H, et al. Suppression of intracellular Cu-Zn SOD results in enhanced motility and metastasis of Meth A sarcoma cells. Int J Cancer 1997;73:187-92.
28. Greenwald RA, Moy WW. Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum 1979;22:251-9.
29. Simon RH, Scoggin CH, Patterson D. Hydrogen peroxide causes fatal injury to human fibroblasts exposed to oxygen radicals. J Biol Chem 1981;259:7181-6.
30. Bates EJ, Lowther DA, Handley CK. Oxygen free radicals mediate an inhibition of proteoglycan synthesis in cultured articular cartilage. Ann Rheum Dis 1984;43:462-9.
31. Shingu M, Nobunaga M. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide. Am J Pathol 1984;117:201-6.
32. Shingu M, Nonaka S, Nishimukai H, Nobunaga M, Kitamura H, Tomooka K. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exp Immunol 1992;90:72-8.
33. Weiss SJ, Peppin G, Oritz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985;227:247-9.
34. Wang S, Leonard SS, Castranova V, Vallyathan V, Shi X. The role of superoxide radical in TNF-α induced NK-KB activation. Ann Clin Lab Sci 1999;29:192-9.
35. Kowanko IC, Ferranta A, Clemente G, Youssef PP, Smith M. Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients. J Clin Immunol 1996;16:216-21.
36. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poster J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990;85:632-9.
37. Shingu M, Isayama T, Yasutake C, Naono T, Nobunaga M, Tomari K, et al. Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation. Inflammation 1994;18:613-23.
38. Evans DM, Ralston SH. Nitric oxide and bone. J Bone Miner Res 1996;11:300-5.
39. Nishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, Tomita T, et al. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol 2000;12:187-93.
40. Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, et al. Clinical protocol: clinical trial to assess the safety, feasibility, and efficacy of tranferring a potentially antiarthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996;7:1261-80.
41. Ahmadzadeh N, Shingu M, Nobunaga M. The effect of recombinant tumor necrosis factor-α on superoxide and metalloproteinase production by synovial cells and chondrocytcs. Clin Exp Rheumatol 1990;8:387-91.
42. Price FM, Levick JR, Mason RM. Glycosaminoglycan concentration in synovium and other tissues of rabbit knee in relation to synovial hydraulic resistance. J Physiol 1996;495:803-20.
43. Challita PM, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A 1994;91:2567-71.
44. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther 2000;7:24-30.
45. Torono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000;7:20-3.
46. Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD, Hoon DS. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Ther 1997;4:969-76.